The Hospice Advanced Dementia Symptom Management and Quality of Life Trial

Dementia Clinical Trial

— HAS-QOL  

Official title:

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03681119
• Other study ID #: 18-01265
• Status: Completed
• Phase: N/A
• Start date: February 11, 2019
• Est. completion date: June 12, 2019

Study information

• Verified date: August 2020
• Source: NYU Langone Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia annually are cared for in hospice, yet hospice agencies are ill prepared to care for this population and often resort to inappropriate pharmacologic measures such as antipsychotics that reduce quality of life rather than improve it. This study will therefore through its two phases refine and then implement, using a pragmatic stepped wedge trial design, the Dementia Symptom Management at Home Program Hospice Edition, with the goal improving quality of care for the person with dementia and their caregiver, reducing antipsychotic use, and increasing bereaved caregiver satisfaction in the hospice setting.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 83
• Est. completion date: June 12, 2019
• Est. primary completion date: June 12, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• Must have dementia as primary diagnosis for admission to hospice

• Must be newly admitted to a participating hospice

• Must be 50 years or older

Clinicians:

• Must be a skilled clinician or home health aide who provides care through an eligible home health agency

• Must be 18 years or older

Exclusion Criteria:

Persons with Dementia:

• None

Clinicians:

• None

Related Conditions & MeSH terms

• Dementia

Intervention

Behavioral:
• Dementia symptom management at home hospice edition
Quality assurance performance improvement program
• Education and Training
Education and training

Locations

Country	Name	City	State
United States	New York University School of Medicine	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
NYU Langone Health	National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of Hospice IDT Members Who Complete Required Education and Training	Percentage of Hospice IDT Members who Complete Required Education and Training	2 Months